Skip to content
lsd.com

Indication

Gastrointestinal Cancer

2 registered trials testing Psilocybin, Ketamine for this indication, none currently recruiting.

2
Registered trials
0
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Gastrointestinal Cancer trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Gastrointestinal Cancer

TrialStatusPhaseSubstanceSites
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal CancersNCT05220046 · University of NebraskaCompletedPhase 1psilocybin1
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI CancersNCT06001372 · University of UtahTerminatedEarly Phase 1ketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.